Hemab Therapeutics

Biotechnology ResearchCopenhagen, Capital Region of Denmark, DenmarkFounded 2020102 employees$347M raised

Hemab Therapeutics is a clinical-stage biotech company developing antibody-based treatments for rare bleeding and clotting disorders. The company has raised $347M and employs 102 people across its Cambridge, MA and Copenhagen, Denmark locations.

Employees
102
Total raised
$347M
Last: Series C
Open roles
7
0% vs last year
Site visitors
7K
per month
Alumni founders

The growth story

Hemab Therapeutics headcount and funding102 people today
102$135M$157M10220222023202420252026
Data by CrustdataCrustdata

Hemab Therapeutics grew from 17 to 102 employees between 2022 and 2026, raising $347M along the way, most recently a Series C in October 2025.

About

Hemab develops monoclonal and bispecific antibody therapies targeting underserved bleeding and thrombotic disorders like Glanzmann Thrombasthenia and Von Willebrand Disease. Its pipeline aims to deliver five clinical assets by 2025.

The company has raised $347M in funding, including a Series C round in 2025. With 102 employees, Hemab operates dual headquarters in Cambridge, Massachusetts and Copenhagen, Denmark.

Founders and leadership

Hemab's largest function is Research, with 9 employees. The company is led by executives with backgrounds in biotech and pharmaceuticals.

The Hemab Therapeutics org chart

Benny Sorensen (Chief Executive Officer) leads 59 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.

Departments, and which ones grew

Headcount by functiongrowth vs 12 months ago
RResearch
28+33%
HHealthcare Services
10+43%
BBusiness Development
9-31%
OOperations
6+20%
FFinance
6+50%
IInformation Technology
4+100%
LLegal
4+33%
CCommunity and Social Services
4+100%
AAdministrative
4+100%
Data by CrustdataCrustdata

Headcount by function: Research 28 (+33% YoY), Healthcare Services 10 (+43% YoY), Business Development 9 (-31% YoY), Operations 6 (+20% YoY), Finance 6 (+50% YoY), Information Technology 4 (+100% YoY).

Talent flow

Hemab recruits heavily from Novo Nordisk, Alnylam Pharmaceuticals, and Genmab. Its employees have a median tenure of 2 years, with some moving to firms like Takeda and RA Capital Management.

Where Hemab Therapeutics people come from, and where they go91 current + 27 former profiles
29 people: Novo Nordisk → Hemab Therapeutics14 people: Alnylam Pharmaceuticals → Hemab Therapeutics8 people: Genmab → Hemab Therapeutics7 people: Biogen → Hemab Therapeutics6 people: Takeda → Hemab Therapeutics5 people: bluebird bio → Hemab Therapeutics5 people: LEO Pharma → Hemab Therapeutics5 people: Ascendis Pharma → Hemab Therapeutics3 people: Hemab Therapeutics → Novo1 people: Hemab Therapeutics → Arkin Capital1 people: Hemab Therapeutics → Ori Rehab1 people: Hemab Therapeutics → RA Capital Management1 people: Hemab Therapeutics → Access Industries1 people: Hemab Therapeutics → Takeda1 people: Hemab Therapeutics → MannKind1 people: Hemab Therapeutics → TMC Pharma ServicesHemab Therapeutics102 peopleCAME FROMWENT TONovo Nordisk29 peopleAlnylam Pharmaceuti…14 peopleGenmab8 peopleBiogen7 peopleTakeda6 peoplebluebird bio5 peopleLEO Pharma5 peopleAscendis Pharma5 peopleNovo3 peopleArkin Capital1 peopleOri Rehab1 peopleRA Capital Manageme…1 peopleAccess Industries1 peopleTakeda1 peopleMannKind1 peopleTMC Pharma Services1 people
Data by CrustdataCrustdata

Most common previous employers of Hemab Therapeutics staff: Novo Nordisk (29), Alnylam Pharmaceuticals (14), Genmab (8), Biogen (7), Takeda (6), bluebird bio (5). Former Hemab Therapeutics employees most often moved to Novo (3), Arkin Capital (1), Ori Rehab (1), RA Capital Management (1), Access Industries (1), Takeda (1).

Alumni worth knowing

Hiring now

Vice President, Global Head of Drug Safety (DS) & Pharmacovigilance (PV)Senior Director of Clinical Operations - sutacimig programSenior Clinical Trial ManagerScientist, Quantitative Clinical Pharmacology (PK/PD Modeling & Simulation)Director/Senior Director of Clinical Research

Web traffic

hemab.com monthly visitors-33% month over month
1575,0369,9156,674202420252026
Data by CrustdataCrustdata

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.

What this company is made of

Headcount by skillwhat people list on their profiles
PPharmaceutics
34
BBiotechnology
33
CClinical Trials
30
LLife Sciences
27
LLeadership
21
CClinical Research
21
RResearch Skills
19
CClinical Development
18
DDrug Development
18
CCell Culture
18
Data by CrustdataCrustdata

Most common skills at Hemab Therapeutics: Pharmaceutics (34), Biotechnology (33), Clinical Trials (30), Life Sciences (27), Leadership (21), Clinical Research (21), Research Skills (19), Clinical Development (18).

Where the team actually sits

Headcount by regionHQ: Copenhagen, Capital Region of Denmark, Denmark
CCapital Region of Denmark, Denmark
37
MMassachusetts, United States
21
GGreater Boston
13
UUnited States
3
CCopenhagen Metropolitan Area
2
VVienna, Austria
2
NNorth Carolina, United States
2
DDenmark
2
Data by CrustdataCrustdata

Hemab Therapeutics people are concentrated in Capital Region of Denmark, Denmark (37), Massachusetts, United States (21), Greater Boston (13), United States (3).

Search footprint

Organic clicks
82
per month
Traffic worth
$0K
if bought as ads
Ranking keywords
186

Hemab Therapeutics attracts about 82 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 29 ranking keywords and lost 14 in the last period.

Frequently asked

How many employees does Hemab Therapeutics have?

Hemab Therapeutics has 102 employees as of September 2026.

How much has Hemab Therapeutics raised?

Hemab Therapeutics has raised $347M in total, most recently a Series C round in October 2025.

Who founded Hemab Therapeutics?

Hemab Therapeutics was founded in 2020 by Hans H Wandall.

Who is the CEO of Hemab Therapeutics?

Benny Sorensen (Chief Executive Officer) sits at the top of Hemab Therapeutics's reporting structure, with 6 direct reports.

Where does Hemab Therapeutics hire from?

The most common previous employers of current Hemab Therapeutics staff are Novo Nordisk (29 people), Alnylam Pharmaceuticals (14 people), Genmab (8 people).

Where do Hemab Therapeutics employees go after leaving?

Former Hemab Therapeutics employees most often move to Novo (3), Arkin Capital (1), Ori Rehab (1).

How much traffic does Hemab Therapeutics get from search?

Hemab Therapeutics attracts about 82 organic search visits a month, worth roughly $0K a month in equivalent ad spend.

What skills do people at Hemab Therapeutics have?

The most common skills among Hemab Therapeutics staff are Pharmaceutics, Biotechnology, Clinical Trials, Life Sciences, Leadership.

Where is Hemab Therapeutics's team located?

Hemab Therapeutics staff are concentrated in Capital Region of Denmark, Denmark (37), Massachusetts, United States (21), Greater Boston (13).

How big is Hemab Therapeutics's research team?

Hemab Therapeutics has about 28 people in Research, up 33% over the past year, as of September 2026.

How big is Hemab Therapeutics's healthcare services team?

Hemab Therapeutics has about 10 people in Healthcare Services, up 43% over the past year, as of September 2026.

Computed from 91 current and 27 former Hemab Therapeutics profiles, as of September 2026. Source: Crustdata.

Build this for any company

Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.

See it Live in ActionRead the API docs